Japanese subgroup analysis in the Asian phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma.
Negoro E, Yamauchi T, Fukuhara N, Yamamoto K, Uchida T, Izutsu K, Maruyama D, Terui Y, Nakajima H, Ando K, Suehiro Y, Choi I, Kanemura N, Nakamura N, Yamamoto G, Maeda Y, Shibayama H, Nagahama F, Sonehara Y, Nagai H, Tien HF, Kwong YL, Kim WS, Tobinai K.
Negoro E, et al. Among authors: nagahama f.
J Clin Exp Hematop. 2023;63(2):108-120. doi: 10.3960/jslrt.23005.
J Clin Exp Hematop. 2023.
PMID: 37380467
Free PMC article.
Clinical Trial.